MedTrace Logo

Progression to Impaired Glucose Tolerance and Type 2 Diabetes in the Korean People-based KNDP Study

NCT01034826 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2010-06-09

No results posted yet for this study

Summary

Impaired glucose tolerance is a metabolic state between normal glucose homeostasis and diabetes. Previously, prospective studies have shown higher progression rates from IGT to diabetes in other country. But There is no prospective-multicenter based reports in Korea. Therefore, the purpose of this study is to estimate the progression rates to impair glucose regulation and diabetes in the Korean population-based Korea national Diabetes program.

Conditions

Sponsors & Collaborators

  • Korea University Guro Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2009-12-31
Completion
2010-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01034826 on ClinicalTrials.gov